Skip to main content

Duke Cancer Institute

Duke Cancer Institute Logo
  • DCI Blog
  • Events
  • DCI Members
  • Contact
  • Give
Cancer Types and Programs
  • Primary Brain Cancer
  • Brain and Spine Metastasis
  • Breast Cancer
  • Endocrine Neoplasia
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hematologic Malignancies and Cellular Therapy
  • Immunotherapy
  • Melanoma and Advanced Skin Cancers
  • Molecular Tumor Board
  • Oncologic Reconstructive Surgery
  • Pancreatic Cancer
  • Pediatric Cancers
  • Prostate and Urologic Cancers
  • Sarcoma
  • Thoracic Cancer
  • Thyroid Cancer
Supportive Care
  • Supportive Care and Survivorship Center
Research
  • Cancer Registry
  • Clinical Trials
  • Research Programs
  • Shared Resources
Education and Training
  • Office of Cancer Research Training and Education Coordination
About DCI
  • DCI Overview
  • DCI Members
  • Nursing
  • Careers
  • Community Outreach and Engagement
  • Contact
  • DCI blog
  • Events
Get Involved
  • Giving Opportunities
  • Benefits and Special Events
  • Breakthroughs Magazine
Make an Appointment
  • Blogs
Arif sitting on a couch and smiling
Arif Kamal, MD, MBA, MHS, FACP, FAAHPM, FASCO

Kamal Named First Chief Patient Officer for ACS

Published

December 06, 2021

Topics

  • Recognitions

Share

Share This Page

Twitter

Print Page Or Copy Link Url

Copied to clipboard

Related News

Angeles Alvarez Secord
Angeles Alvarez Secord
News Mention

NRG Oncology Adds New Leadership Members to Ancillary Projects, Investigator & Career Development, Medical Oncology, Patient-Centered Outcomes Research, and Surgical Oncology Committees & Sarcoma Subcommittee

March 30, 2026
NRG Oncology
Gayle Ackerman DiLalla
Gayle Ackerman DiLalla
News Mention

Gayle DiLalla, MD, Named AWSF 2026 Kim Ephgrave Visiting Professor

March 25, 2026
Duke Surgery

Related News

Angeles Alvarez Secord
Angeles Alvarez Secord
News Mention

NRG Oncology Adds New Leadership Members to Ancillary Projects, Investigator & Career Development, Medical Oncology, Patient-Centered Outcomes Research, and Surgical Oncology Committees & Sarcoma Subcommittee

March 30, 2026
NRG Oncology
Gayle Ackerman DiLalla
Gayle Ackerman DiLalla
News Mention

Gayle DiLalla, MD, Named AWSF 2026 Kim Ephgrave Visiting Professor

March 25, 2026
Duke Surgery
Duke Cancer Institute
Facebook Instagram Twitter YouTube RSS
  • Cancer Types
  • Primary Brain Cancer
  • Brain and Spine Metastasis
  • Breast Cancer
  • Endocrine Neoplasia
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hematologic Malignancies and Cellular Therapy
  • Melanoma and Advanced Skin Cancers
  • Pediatric Cancers
  • Prostate and Urologic Cancers
  • Sarcoma
  • Thoracic Cancer
  • Cancer Therapies
  • Immunotherapy
  • Molecular Tumor Board
  • Supportive Care
  • Supportive Care and Survivorship Center
  • Research
  • Cancer Registry
  • Clinical Trials
  • Research Programs
  • Shared Resources
  • Education and Training
  • About DCI
  • DCI Members
  • Nursing
  • Careers
  • Community Outreach and Engagement
  • Give To DCI
  • Benefits and Special Events
  • Breakthroughs Magazine
  • DCI Blog
  • Primary Brain Cancer
  • Brain and Spine Metastasis
  • Breast Cancer
  • Endocrine Neoplasia
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hematologic Malignancies and Cellular Therapy
  • Melanoma and Advanced Skin Cancers
  • Pediatric Cancers
  • Prostate and Urologic Cancers
  • Sarcoma
  • Thoracic Cancer
  • Immunotherapy
  • Molecular Tumor Board
  • Supportive Care and Survivorship Center
  • Cancer Registry
  • Clinical Trials
  • Research Programs
  • Shared Resources
Education and Training
  • DCI Members
  • Nursing
  • Careers
  • Community Outreach and Engagement
  • Benefits and Special Events
  • Breakthroughs Magazine
DCI Blog
  • Website Privacy Policy
  • Sitemap
  • Leading with Heart: Serving Humanity
  • Notice of Nondiscrimination
  • Notice of Privacy Practices
  • Terms and Conditions
  • Accessibility
  • © DUKE CANCER INSTITUTE 2026
Back to Top